| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5700280 | Clinical Oncology | 2006 | 7 Pages |
Abstract
Brachytherapy was generally well tolerated, with urinary toxicity in most patients persisting for at least 3-6 months after prostate brachytherapy. Those whose pre-treatment prostate volume and IPSS were high experienced more severe urinary symptoms in the first few months.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
K. Kelly, R. Swindell, J. Routledge, M. Burns, J.P. Logue, J.P. Wylie,